Tuesday, March 29, 2022 7:51:58 PM
On July 17, 2020 based on your1 request, the Food and Drug Administration (FDA) issued an
Emergency Use Authorization (EUA) for emergency use of the Rapid COVID-19 IgM/IgG
Combo Test Kit pursuant to Section 564 of the Federal Food, Drug, and Cosmetic Act (the Act)
(21 U.S.C. §360bbb-3) for the qualitative detection and differentiation of IgG and IgM
antibodies to SARS-CoV-2 in human serum and acid citrate dextrose (ACD) plasma. Your
product was intended for use as an aid in identifying individuals with an adaptive immune
response to SARS-CoV-2, indicating recent or prior infection. Testing was limited to laboratories
certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C.
263a, that meet requirements to perform moderate or high complexity tests.
On February 27, 2021, you requested to revise your EUA. Based on that request, and having
concluded that revising the July 17, 2020, EUA is appropriate to protect the public health or
safety under section 564(g)(2)(C) of the Act (21 U.S.C. § 360bbb-3(g)(2)(C)), FDA is reissuing
the July 17, 2020, letter in its entirety with the revisions incorporated.2 Pursuant to section 564
of the Act and the Scope of Authorization (Section II) and Conditions of Authorization (Section
IV) of this reissued letter, your product3 is now authorized for use consistent with the indication
described above.
Recent AXIM News
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/22/2024 08:53:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 08:24:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 04:59:09 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:29:50 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 09/21/2023 03:07:21 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 08/31/2023 08:10:23 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 05:35:50 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 08:11:37 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM